ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

Curtis A Lachowiez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.